AU2011258819B2 - Apparatus and method of monitoring and responding to respiratory depression - Google Patents
Apparatus and method of monitoring and responding to respiratory depression Download PDFInfo
- Publication number
- AU2011258819B2 AU2011258819B2 AU2011258819A AU2011258819A AU2011258819B2 AU 2011258819 B2 AU2011258819 B2 AU 2011258819B2 AU 2011258819 A AU2011258819 A AU 2011258819A AU 2011258819 A AU2011258819 A AU 2011258819A AU 2011258819 B2 AU2011258819 B2 AU 2011258819B2
- Authority
- AU
- Australia
- Prior art keywords
- patient
- narcotic
- naloxone
- reversal agent
- signal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000012544 monitoring process Methods 0.000 title claims abstract description 67
- 208000004756 Respiratory Insufficiency Diseases 0.000 title claims abstract description 22
- 206010038678 Respiratory depression Diseases 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims description 31
- 230000003533 narcotic effect Effects 0.000 claims abstract description 58
- 229960004127 naloxone Drugs 0.000 claims abstract description 47
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 claims abstract description 47
- 239000004081 narcotic agent Substances 0.000 claims abstract description 18
- 230000004044 response Effects 0.000 claims abstract description 18
- 230000000241 respiratory effect Effects 0.000 claims abstract description 17
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 38
- 229910052760 oxygen Inorganic materials 0.000 claims description 38
- 239000001301 oxygen Substances 0.000 claims description 38
- 239000012313 reversal agent Substances 0.000 claims description 24
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 22
- 238000001990 intravenous administration Methods 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 17
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 16
- 230000036387 respiratory rate Effects 0.000 claims description 14
- 238000004891 communication Methods 0.000 claims description 12
- 238000001514 detection method Methods 0.000 claims description 11
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 9
- 238000002106 pulse oximetry Methods 0.000 claims description 8
- 239000001569 carbon dioxide Substances 0.000 claims description 7
- 230000036592 analgesia Effects 0.000 claims description 6
- 208000008784 apnea Diseases 0.000 claims description 6
- 230000036772 blood pressure Effects 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 230000000638 stimulation Effects 0.000 claims description 6
- 230000000474 nursing effect Effects 0.000 claims description 5
- 239000007922 nasal spray Substances 0.000 claims description 4
- 229940097496 nasal spray Drugs 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 239000007789 gas Substances 0.000 claims description 3
- 210000003105 phrenic nerve Anatomy 0.000 claims description 3
- 230000000202 analgesic effect Effects 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 2
- 230000001413 cellular effect Effects 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 230000006461 physiological response Effects 0.000 claims 1
- 230000002980 postoperative effect Effects 0.000 abstract description 13
- 239000003795 chemical substances by application Substances 0.000 abstract description 8
- 239000003814 drug Substances 0.000 description 24
- 229940079593 drug Drugs 0.000 description 24
- 229960003965 antiepileptics Drugs 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 10
- 230000002441 reversible effect Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 230000034994 death Effects 0.000 description 7
- 231100000517 death Toxicity 0.000 description 7
- 230000036407 pain Effects 0.000 description 7
- 230000009471 action Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012806 monitoring device Methods 0.000 description 6
- 201000002859 sleep apnea Diseases 0.000 description 6
- 208000029028 brain injury Diseases 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- OFBIFZUFASYYRE-UHFFFAOYSA-N flumazenil Chemical compound C1N(C)C(=O)C2=CC(F)=CC=C2N2C=NC(C(=O)OCC)=C21 OFBIFZUFASYYRE-UHFFFAOYSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 238000002483 medication Methods 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 229930003347 Atropine Natural products 0.000 description 3
- 208000010496 Heart Arrest Diseases 0.000 description 3
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 3
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 3
- 229960000396 atropine Drugs 0.000 description 3
- 229940049706 benzodiazepine Drugs 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- AQNDDEOPVVGCPG-UHFFFAOYSA-N esmolol Chemical compound COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1 AQNDDEOPVVGCPG-UHFFFAOYSA-N 0.000 description 3
- 229960003745 esmolol Drugs 0.000 description 3
- 229940127240 opiate Drugs 0.000 description 3
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 3
- 229960001802 phenylephrine Drugs 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 229930182837 (R)-adrenaline Natural products 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 208000007204 Brain death Diseases 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- 208000000094 Chronic Pain Diseases 0.000 description 2
- VPNYRYCIDCJBOM-UHFFFAOYSA-M Glycopyrronium bromide Chemical compound [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 VPNYRYCIDCJBOM-UHFFFAOYSA-M 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010038669 Respiratory arrest Diseases 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 2
- 102000002852 Vasopressins Human genes 0.000 description 2
- 108010004977 Vasopressins Proteins 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 239000000729 antidote Substances 0.000 description 2
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 2
- 150000001557 benzodiazepines Chemical class 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000006931 brain damage Effects 0.000 description 2
- 231100000874 brain damage Toxicity 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229940088029 cardizem Drugs 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 2
- HDRXZJPWHTXQRI-BHDTVMLSSA-N diltiazem hydrochloride Chemical compound [Cl-].C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CC[NH+](C)C)C2=CC=CC=C2S1 HDRXZJPWHTXQRI-BHDTVMLSSA-N 0.000 description 2
- 229960005139 epinephrine Drugs 0.000 description 2
- 229960004381 flumazenil Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 208000012866 low blood pressure Diseases 0.000 description 2
- 229940124583 pain medication Drugs 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229940098196 romazicon Drugs 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 229940072690 valium Drugs 0.000 description 2
- 229960003726 vasopressin Drugs 0.000 description 2
- DIWRORZWFLOCLC-HNNXBMFYSA-N (3s)-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound N([C@H](C(NC1=CC=C(Cl)C=C11)=O)O)=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-HNNXBMFYSA-N 0.000 description 1
- XYGVIBXOJOOCFR-BTJKTKAUSA-N (z)-but-2-enedioic acid;8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo[1,5-a][1,4]benzodiazepine Chemical compound OC(=O)\C=C/C(O)=O.C12=CC(Cl)=CC=C2N2C(C)=NC=C2CN=C1C1=CC=CC=C1F XYGVIBXOJOOCFR-BTJKTKAUSA-N 0.000 description 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- UCTWMZQNUQWSLP-UHFFFAOYSA-N Adrenaline Natural products CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 206010007617 Cardio-respiratory arrest Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010028735 Nasal congestion Diseases 0.000 description 1
- 206010033296 Overdoses Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 229940102884 adrenalin Drugs 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 238000002052 colonoscopy Methods 0.000 description 1
- 229940124446 critical care medicine Drugs 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 229940015042 glycopyrrolate Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229960004391 lorazepam Drugs 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229940106905 robinul Drugs 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 239000003421 short acting drug Substances 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 230000005236 sound signal Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/083—Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
- A61B5/0836—Measuring rate of CO2 production
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4821—Determining level or depth of anaesthesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/0051—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes with alarm devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes operated by electrical means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/104—Preparation of respiratory gases or vapours specially adapted for anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/08—Inhaling devices inserted into the nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/06—Respiratory or anaesthetic masks
- A61M16/0666—Nasal cannulas or tubing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0016—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the smell sense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0027—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the hearing sense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0072—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus with application of electrical currents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0077—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus with application of chemical or pharmacological stimulus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0083—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus especially for waking up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0208—Oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0241—Anaesthetics; Analgesics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3375—Acoustical, e.g. ultrasonic, measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3561—Range local, e.g. within room or hospital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/04—Heartbeat characteristics, e.g. ECG, blood pressure modulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/205—Blood composition characteristics partial oxygen pressure (P-O2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/208—Blood composition characteristics pH-value
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/30—Blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/40—Respiratory characteristics
- A61M2230/42—Rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/40—Respiratory characteristics
- A61M2230/43—Composition of exhalation
- A61M2230/432—Composition of exhalation partial CO2 pressure (P-CO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3925—Monitoring; Protecting
- A61N1/3937—Monitoring output parameters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Acoustics & Sound (AREA)
- Psychology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34835410P | 2010-05-26 | 2010-05-26 | |
| US61/348,354 | 2010-05-26 | ||
| US35248010P | 2010-06-08 | 2010-06-08 | |
| US61/352,480 | 2010-06-08 | ||
| US37240410P | 2010-08-10 | 2010-08-10 | |
| US61/372,404 | 2010-08-10 | ||
| US12/946,698 US8695591B2 (en) | 2010-05-26 | 2010-11-15 | Apparatus and method of monitoring and responding to respiratory depression |
| US12/946,698 | 2010-11-15 | ||
| PCT/US2011/024977 WO2011149570A1 (en) | 2010-05-26 | 2011-02-16 | Apparatus and method of monitoring and responding to respiratory depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2011258819A1 AU2011258819A1 (en) | 2012-04-12 |
| AU2011258819B2 true AU2011258819B2 (en) | 2013-12-19 |
Family
ID=45004260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2011258819A Ceased AU2011258819B2 (en) | 2010-05-26 | 2011-02-16 | Apparatus and method of monitoring and responding to respiratory depression |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8695591B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2470075B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5903096B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011258819B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011149570A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9265429B2 (en) | 2009-09-18 | 2016-02-23 | Welch Allyn, Inc. | Physiological parameter measuring platform device supporting multiple workflows |
| WO2012024401A2 (en) | 2010-08-17 | 2012-02-23 | University Of Florida Research Foundation, Inc. | Intelligent drug and/or fluid delivery system to optimizing medical treatment or therapy using pharmacodynamic and/or pharmacokinetic data |
| US20130172759A1 (en) | 2011-08-08 | 2013-07-04 | Richard J. Melker | Systems And Methods For Using Photoplethysmography In The Administration Of Narcotic Reversal Agents |
| WO2013138592A1 (en) * | 2012-03-14 | 2013-09-19 | Lloyd Olson | Monitoring and delivery system for supplying patient with controlled dosage of substance reversal agent |
| US9235682B2 (en) | 2012-04-05 | 2016-01-12 | Welch Allyn, Inc. | Combined episodic and continuous parameter monitoring |
| US9055870B2 (en) | 2012-04-05 | 2015-06-16 | Welch Allyn, Inc. | Physiological parameter measuring platform device supporting multiple workflows |
| USD772252S1 (en) | 2012-04-05 | 2016-11-22 | Welch Allyn, Inc. | Patient monitoring device with a graphical user interface |
| USD916713S1 (en) | 2012-04-05 | 2021-04-20 | Welch Allyn, Inc. | Display screen with graphical user interface for patient central monitoring station |
| US10226200B2 (en) | 2012-04-05 | 2019-03-12 | Welch Allyn, Inc. | User interface enhancements for physiological parameter monitoring platform devices |
| EP2854636B1 (en) * | 2012-05-30 | 2019-08-21 | ResMed Sensor Technologies Limited | Method and apparatus for monitoring cardio-pulmonary health |
| US10525219B2 (en) | 2012-06-26 | 2020-01-07 | Resmed Sensor Technologies Limited | Methods and apparatus for monitoring and treating respiratory insufficiency |
| US20140081659A1 (en) | 2012-09-17 | 2014-03-20 | Depuy Orthopaedics, Inc. | Systems and methods for surgical and interventional planning, support, post-operative follow-up, and functional recovery tracking |
| US20150367071A1 (en) * | 2013-02-04 | 2015-12-24 | The Uab Research Foundation | Systems and methods for tracking and reversing accidental overdose |
| AU2014275572B2 (en) | 2013-06-05 | 2019-03-28 | Fisher & Paykel Healthcare Limited | Breathing control using high flow respiration assistance |
| US10476921B2 (en) | 2013-06-12 | 2019-11-12 | Carefusion 303, Inc. | System event notification |
| US9724341B2 (en) * | 2013-07-11 | 2017-08-08 | Alexza Pharmaceuticals, Inc. | Nicotine salt with meta-salicylic acid |
| US20160328993A1 (en) * | 2014-01-09 | 2016-11-10 | Healthbits Corporation | Location agnostic platform for medical condition monitoring and prediction and method of use thereof |
| WO2016073604A1 (en) * | 2014-11-04 | 2016-05-12 | Respiratory Motion, Inc. | Respiratory parameter guided automated iv administration and iv tube clamp activation |
| CN104740740A (zh) * | 2015-04-06 | 2015-07-01 | 谭高霞 | 综合监护式呼吸麻醉机 |
| US20180126075A1 (en) * | 2016-10-21 | 2018-05-10 | Arkham Enterprises, Llc | System, device and method for automated treatment of symptoms associated with nerve gas exposure |
| US20180110923A1 (en) * | 2016-10-21 | 2018-04-26 | Arkham Enterprises, Llc | System and methods for overdose mitigation |
| US11426513B2 (en) | 2016-11-29 | 2022-08-30 | Geoffrey Louis Tyson | Implantable devices for drug delivery in response to detected biometric parameters associated with an opioid drug overdose and associated systems and methods |
| US11617847B2 (en) | 2017-01-11 | 2023-04-04 | Model Software Corporation | Methods for minimizing delayed effects of exposure to reduced oxygen partial pressure via administration of supplemental oxygen |
| US10532175B1 (en) | 2019-05-23 | 2020-01-14 | Model Software Corporation | Methods for minimizing delayed effects of exposure to reduced oxygen partial pressure via administration of supplemental oxygen |
| US20180193584A1 (en) * | 2017-01-11 | 2018-07-12 | Model Software Corporation | Methods for minimizing delayed effects of exposure to reduced oxygen partial pressure via administration of supplemental oxygen |
| WO2018204204A1 (en) * | 2017-05-04 | 2018-11-08 | Medipines Ccorporation | Systems and methods for stimulating a patient to prevent oxygen desaturation |
| US10229573B1 (en) * | 2017-05-06 | 2019-03-12 | David Lawrie | Immediate alert for tracking movement via wireless tethered devices |
| US20190125256A1 (en) * | 2017-10-30 | 2019-05-02 | Hays, Inc. | Automatic Drug Administration Device and Method |
| US10390699B2 (en) | 2018-01-17 | 2019-08-27 | Vincenzo Grande | Detection and response system for opioid overdoses |
| US20210161465A1 (en) * | 2018-06-06 | 2021-06-03 | Masimo Corporation | Kit for opioid overdose monitoring |
| WO2021189002A1 (en) | 2020-03-20 | 2021-09-23 | Masimo Corporation | Wearable device for noninvasive body temperature measurement |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030106553A1 (en) * | 2001-12-06 | 2003-06-12 | Vanderveen Timothy W. | CO2 monitored drug infusion system |
| US20050182389A1 (en) * | 2001-04-30 | 2005-08-18 | Medtronic, Inc | Implantable medical device and patch system and method of use |
| WO2010093677A2 (en) * | 2009-02-12 | 2010-08-19 | Oregon Health & Science University | Method and apparatus for prevention of apnea |
Family Cites Families (100)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4280494A (en) * | 1979-06-26 | 1981-07-28 | Cosgrove Robert J Jun | System for automatic feedback-controlled administration of drugs |
| DE3608475A1 (de) | 1986-03-14 | 1987-09-17 | Gerd Prof Dr Kobal | Verfahren und einrichtung zur messung von sensorischen qualitaeten |
| US20050062609A9 (en) | 1992-08-19 | 2005-03-24 | Lynn Lawrence A. | Pulse oximetry relational alarm system for early recognition of instability and catastrophic occurrences |
| US7081095B2 (en) | 2001-05-17 | 2006-07-25 | Lynn Lawrence A | Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions |
| US5836300A (en) | 1996-03-11 | 1998-11-17 | Mault; James R. | Metabolic gas exchange and noninvasive cardiac output monitor |
| US6135107A (en) | 1996-03-11 | 2000-10-24 | Mault; James R. | Metabolic gas exchange and noninvasive cardiac output monitor |
| US5857460A (en) | 1996-03-14 | 1999-01-12 | Beth Israel Deaconess Medical Center, Inc. | Gas-sensing mask |
| US5957885A (en) | 1996-11-06 | 1999-09-28 | Alaris Medical Systems, Inc. | Oximetry monitored, patient controlled analgesia system |
| US6579592B1 (en) | 1996-11-29 | 2003-06-17 | Fuji Photo Film Co., Ltd | Magnetic recording tape with controlled Hc and magnetic flux/unit area value and controlled Cl/Fe intensity |
| US6309360B1 (en) | 1997-03-17 | 2001-10-30 | James R. Mault | Respiratory calorimeter |
| US6131571A (en) | 1997-04-30 | 2000-10-17 | University Of Florida | Ventilation apparatus and anesthesia delivery system |
| US6076392A (en) | 1997-08-18 | 2000-06-20 | Metasensors, Inc. | Method and apparatus for real time gas analysis |
| US6002133A (en) | 1997-08-19 | 1999-12-14 | Datex-Ohmeda, Inc. | Serviceable absorbent for gas spectrometer interior |
| US6099481A (en) | 1997-11-03 | 2000-08-08 | Ntc Technology, Inc. | Respiratory profile parameter determination method and apparatus |
| US6572561B2 (en) | 1998-01-16 | 2003-06-03 | Healthetech, Inc. | Respiratory calorimeter |
| US7308894B2 (en) * | 1998-06-03 | 2007-12-18 | Scott Laboratories, Inc. | Apparatuses and methods for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures according to appropriate clinical heuristics |
| EP1082056B1 (en) | 1998-06-03 | 2007-11-14 | Scott Laboratories, Inc. | Apparatus for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures |
| US7565905B2 (en) | 1998-06-03 | 2009-07-28 | Scott Laboratories, Inc. | Apparatuses and methods for automatically assessing and monitoring a patient's responsiveness |
| US20060093785A1 (en) | 1998-06-03 | 2006-05-04 | Scott Laboratories, Inc. | Apparatus, method and drug products for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures |
| US6216692B1 (en) | 1998-06-19 | 2001-04-17 | Nihon Kohden Corporation | Airway adaptor for measurement of gas concentration |
| US6512581B1 (en) | 1998-06-19 | 2003-01-28 | Nihon Kohden Corporation | Respiratory gas sensor |
| USRE38533E1 (en) | 1998-09-11 | 2004-06-15 | Life Corporation | Portable emergency oxygen and automatic external defibrillator (AED) therapy system |
| US6327497B1 (en) | 1998-09-11 | 2001-12-04 | Life Corporation | Portable emergency oxygen and automatic external defibrillator (AED) therapy system |
| EP1115448A4 (en) | 1998-09-23 | 2002-05-08 | Univ Johns Hopkins | SURVIVAL MATERIAL |
| AU4916500A (en) | 1999-05-04 | 2000-11-17 | Map Medizintechnik Fur Arzt Und Patient Gmbh & Co. Kg | Device for detecting electrical potentials in the forehead-area of a patient |
| SE522908C2 (sv) | 1999-05-10 | 2004-03-16 | Aneo Ab | Arrangemang för att kunna tilldela en levande varelse ett anestesialt tillstånd |
| US6379312B2 (en) | 1999-12-28 | 2002-04-30 | O'toole James | End tidal carbon dioxide sampling device |
| US6629934B2 (en) | 2000-02-02 | 2003-10-07 | Healthetech, Inc. | Indirect calorimeter for medical applications |
| US6615744B1 (en) | 2000-12-07 | 2003-09-09 | Hill-Rom Services, Inc. | Overbed table |
| BR0110596A (pt) | 2000-05-05 | 2005-08-02 | Hill Rom Services Inc | Sistema de monitoramento de paciente, sistema de computador, sistema para monitorar informação de paciente, aparelho de assistência ao paciente, aparelho de andador, aparelho de assistência ao paciente, e, mostrador para um computador |
| US7032522B2 (en) | 2000-05-05 | 2006-04-25 | Hill-Rom Services, Inc. | Overbed table for use with a patient support |
| CA2408258A1 (en) | 2000-05-05 | 2001-11-15 | Hill Rom Services, Inc. | Hospital monitoring and control system and method |
| US6938619B1 (en) | 2000-06-13 | 2005-09-06 | Scott Laboratories, Inc. | Mask free delivery of oxygen and ventilatory monitoring |
| US20050066968A1 (en) | 2000-08-01 | 2005-03-31 | Shofner Frederick M. | Generation, delivery, measurement and control of aerosol boli for diagnostics and treatments of the respiratory/pulmonary tract of a patient |
| AU2001287175A1 (en) | 2000-08-11 | 2002-02-25 | Healthetech, Inc. | Achieving a relaxed state |
| US20020139368A1 (en) | 2001-03-29 | 2002-10-03 | Bachinski Thomas J. | Oxygen sensor mounting in medical or flight crew masks for direct indication of blood level oxygen |
| US7038588B2 (en) | 2001-05-04 | 2006-05-02 | Draeger Medical Infant Care, Inc. | Apparatus and method for patient point-of-care data management |
| JP2005523042A (ja) | 2001-08-03 | 2005-08-04 | ヒル−ロム サービシーズ,インコーポレイティド | 患者支持体に使用するオーバーベッド・テーブル |
| US20030130595A1 (en) | 2001-08-13 | 2003-07-10 | Mault James R. | Health improvement systems and methods |
| US20030130567A1 (en) | 2002-01-09 | 2003-07-10 | Mault James R. | Health-related devices and methods |
| DE10139881B4 (de) | 2001-08-20 | 2017-06-08 | Resmed R&D Germany Gmbh | Vorrichtung zur Zufuhr eines Atemgases und Verfahren zur Steuerung derselben |
| US7311657B2 (en) | 2001-10-05 | 2007-12-25 | Draeger Medical Systems, Inc. | Patient-support device and docking cart combination |
| ES2323046T3 (es) | 2001-10-05 | 2009-07-06 | Draeger Medical Systems, Inc. | Aparato de soporte de paciente que tiene un sistema de gestion de lineas. |
| WO2003030801A2 (en) | 2001-10-05 | 2003-04-17 | Hill-Rom Services, Inc. | Infant care apparatus |
| JP4593108B2 (ja) | 2001-11-01 | 2010-12-08 | スコット・ラボラトリーズ・インコーポレイテッド | 鎮静および鎮痛送出システムのユーザインタフェース |
| US6985870B2 (en) | 2002-01-11 | 2006-01-10 | Baxter International Inc. | Medication delivery system |
| CN100586499C (zh) | 2002-02-20 | 2010-02-03 | 斯科特实验室公司 | 镇静及止痛系统 |
| IL148468A (en) | 2002-03-03 | 2012-12-31 | Exalenz Bioscience Ltd | Breath collection system |
| AU2003241479B2 (en) | 2002-05-16 | 2008-08-28 | Scott Laboratories, Inc. | System and method for permitting sterile operation of a sedation and analgesia system |
| US7316231B2 (en) | 2002-08-08 | 2008-01-08 | Scott Laboratories, Inc. | Resuscitation kit system and method and pre-use protocols for a sedation and analgesia system |
| WO2004032051A2 (en) | 2002-10-03 | 2004-04-15 | Scott Laboratories, Inc. | Systems and methods for providing sensor fusion |
| EP1554003A4 (en) | 2002-10-03 | 2011-10-12 | Scott Lab Inc | SYSTEMS AND METHODS FOR TREND ANALYSIS IN AN SEDATION AND ANALYSIS SYSTEM |
| AU2003303382A1 (en) | 2002-12-20 | 2004-07-22 | Axon Medical, Inc. | System providing emergency medical care with real-time instructions and associated methods |
| US6709403B1 (en) | 2003-01-07 | 2004-03-23 | Mercury Enterprises, Inc. | Manometer CO2 detector combination |
| JP4247758B2 (ja) | 2003-02-18 | 2009-04-02 | 日本光電工業株式会社 | 炭酸ガス測定センサ |
| MXPA05009455A (es) | 2003-03-04 | 2006-04-07 | Johnson & Johnson | Sistema para monitoreo de paciente y suministro de farmaco y metodo de uso. |
| US6874502B1 (en) | 2003-05-02 | 2005-04-05 | Ramses Nashed | Breathing circuit disconnect warning system and method for using a disconnect system |
| US7610094B2 (en) | 2003-09-18 | 2009-10-27 | Cardiac Pacemakers, Inc. | Synergistic use of medical devices for detecting medical disorders |
| GB0319743D0 (en) | 2003-08-22 | 2003-09-24 | Smiths Group Plc | Resuscitators, parts and assemblies |
| EP1694386B1 (en) | 2003-12-05 | 2017-05-03 | CareFusion 303, Inc. | Patient-controlled analgesia with patient monitoring system |
| JP2007526796A (ja) | 2003-12-15 | 2007-09-20 | アレックザ ファーマシューティカルズ, インコーポレイテッド | 薬剤エアロゾル吸入による突出痛の治療 |
| EP1765442B1 (en) | 2004-06-24 | 2017-08-02 | Convergent Engineering, Inc. | APPARATUS FOR NON-INVASIVE PREDICTION OF INTRINSIC POSITIVE END-EXPIRATORY PRESSURE (PEEPi) IN PATIENTS RECEIVING VENTILATORY SUPPORT |
| DE102004050717B8 (de) | 2004-10-19 | 2006-02-23 | Dräger Medical AG & Co. KGaA | Anästhesievorrichtung |
| EP1861009B1 (en) | 2005-03-17 | 2019-05-22 | Robert E. Coifman | Apparatus and method for intelligent electronic peak flow meters |
| US20060249155A1 (en) | 2005-05-03 | 2006-11-09 | China Resource Group, Inc. | Portable non-invasive ventilator with sensor |
| US8561611B2 (en) | 2005-06-21 | 2013-10-22 | Ric Investments, Llc | Respiratory device measurement system |
| US20070062532A1 (en) | 2005-09-21 | 2007-03-22 | Choncholas Gary J | Apparatus and method for identifying optimal PEEP |
| US20070062533A1 (en) | 2005-09-21 | 2007-03-22 | Choncholas Gary J | Apparatus and method for identifying FRC and PEEP characteristics |
| US7530353B2 (en) | 2005-09-21 | 2009-05-12 | The General Electric Company | Apparatus and method for determining and displaying functional residual capacity data and related parameters of ventilated patients |
| US20070089744A1 (en) | 2005-10-11 | 2007-04-26 | Wiese Scott R | Method for determining a cardiac data characteristic |
| CA2637575A1 (en) * | 2006-01-20 | 2007-07-26 | Daniel J. Abrams | Multi-parameter monitoring device for use with central and intravenous administration of medication |
| GB0607939D0 (en) | 2006-04-21 | 2006-05-31 | Imp College Innovations Ltd | Method and device for stabilising disordered breathing |
| WO2007140478A2 (en) | 2006-05-31 | 2007-12-06 | Masimo Corporation | Respiratory monitoring |
| AU2007353360B2 (en) | 2006-06-13 | 2013-08-29 | Carefusion 303, Inc. | System and method for optimizing control of PCA and PCEA system |
| DE102006032860B4 (de) | 2006-07-14 | 2011-07-14 | Dräger Medical GmbH, 23558 | Überwachungseinrichtung für eine Narkosevorrichtung und Verfahren |
| US7766857B2 (en) | 2006-08-21 | 2010-08-03 | General Electric Company | Non-invasive determination of cardiac output, gas exchange and arterial blood gas concentration |
| US20080066739A1 (en) * | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
| DE202007010052U1 (de) | 2006-10-14 | 2007-10-25 | Dräger Medical AG & Co. KG | Medizinischer Arbeitsplatz mit einem Therapiemodul |
| US8312879B2 (en) | 2006-10-16 | 2012-11-20 | General Electric Company | Method and apparatus for airway compensation control |
| US8312878B2 (en) | 2006-12-04 | 2012-11-20 | Ric Investments, Llc | Compensation of volumetric errors in a gas monitoring system |
| NZ548290A (en) | 2006-12-30 | 2009-09-25 | Safer Sleep Ltd | Notification system |
| US20080171762A1 (en) | 2007-01-16 | 2008-07-17 | Ockert David M | Treatment of pain with naloxone |
| US8020558B2 (en) | 2007-01-26 | 2011-09-20 | Cs Medical, Inc. | System for providing flow-targeted ventilation synchronized to a patient's breathing cycle |
| GB2446124B (en) | 2007-02-02 | 2009-09-09 | Laerdal Medical As | Device for Monitoring Respiration |
| US20080202523A1 (en) | 2007-02-23 | 2008-08-28 | General Electric Company | Setting mandatory mechanical ventilation parameters based on patient physiology |
| WO2008109646A1 (en) | 2007-03-07 | 2008-09-12 | The General Hospital Corporation | Method and device for determining cardiac output with carbon dioxide partial re-breathing |
| EP1972356B1 (en) | 2007-03-22 | 2011-06-29 | General Electric Company | System for monitoring patient's breathing action response to changes in a ventilator applied breathing support |
| US20080230062A1 (en) | 2007-03-23 | 2008-09-25 | General Electric Company | Setting expiratory time in mandatory mechanical ventilation based on a deviation from a stable condition of exhaled gas volumes |
| US20080230060A1 (en) | 2007-03-23 | 2008-09-25 | General Electric Company | Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when tidal volume is inspired |
| US20080230061A1 (en) | 2007-03-23 | 2008-09-25 | General Electric Company | Setting expiratory time in mandatory mechanical ventilation based on a deviation from a stable condition of end tidal gas concentrations |
| US20080230064A1 (en) | 2007-03-23 | 2008-09-25 | General Electric Company | Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when forced inhalation flow ceases |
| US20080236581A1 (en) | 2007-03-29 | 2008-10-02 | Borje Rantala | Method in a patient ventilating system |
| US7980244B2 (en) | 2007-07-17 | 2011-07-19 | Neoforce Group, Inc. | Emergency pulmonary resuscitation device |
| DE102007052897B4 (de) | 2007-11-07 | 2013-02-21 | Dräger Medical GmbH | Verfahren zum automatischen Steuern eines Beatmungssystems sowie zugehöriges Beatmungssystem |
| EP2062531A1 (en) | 2007-11-26 | 2009-05-27 | GE Healthcare Finland Oy | Multiple function airway adapter |
| US8230858B2 (en) | 2008-04-01 | 2012-07-31 | General Electric Company | Controlling the operation of a respiratory gas monitor |
| US20090277447A1 (en) | 2008-05-12 | 2009-11-12 | Advanced Circulatory Systems, Inc. | System, method, and device to increase circulation during cpr without requiring positive pressure ventilation |
| US8409096B2 (en) | 2008-06-20 | 2013-04-02 | University Of Southern California | Breathing circuit with embedded acoustic reflectometer |
| US10252020B2 (en) | 2008-10-01 | 2019-04-09 | Breathe Technologies, Inc. | Ventilator with biofeedback monitoring and control for improving patient activity and health |
| US20130197430A1 (en) | 2010-11-15 | 2013-08-01 | Lloyd Olson | Monitoring and delivery system for supplying patient with controlled dosage of substance reversal agent |
-
2010
- 2010-11-15 US US12/946,698 patent/US8695591B2/en active Active
-
2011
- 2011-02-16 EP EP11787049.3A patent/EP2470075B1/en not_active Not-in-force
- 2011-02-16 AU AU2011258819A patent/AU2011258819B2/en not_active Ceased
- 2011-02-16 WO PCT/US2011/024977 patent/WO2011149570A1/en not_active Ceased
- 2011-02-16 JP JP2013512614A patent/JP5903096B2/ja not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050182389A1 (en) * | 2001-04-30 | 2005-08-18 | Medtronic, Inc | Implantable medical device and patch system and method of use |
| US20030106553A1 (en) * | 2001-12-06 | 2003-06-12 | Vanderveen Timothy W. | CO2 monitored drug infusion system |
| WO2010093677A2 (en) * | 2009-02-12 | 2010-08-19 | Oregon Health & Science University | Method and apparatus for prevention of apnea |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013526982A (ja) | 2013-06-27 |
| US20110290250A1 (en) | 2011-12-01 |
| EP2470075B1 (en) | 2016-06-29 |
| AU2011258819A1 (en) | 2012-04-12 |
| US8695591B2 (en) | 2014-04-15 |
| EP2470075A4 (en) | 2013-03-13 |
| JP5903096B2 (ja) | 2016-04-13 |
| EP2470075A1 (en) | 2012-07-04 |
| WO2011149570A1 (en) | 2011-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2011258819B2 (en) | Apparatus and method of monitoring and responding to respiratory depression | |
| JP7174778B2 (ja) | オピオイド過剰摂取モニタリング | |
| JP4970045B2 (ja) | 患者モニタリングシステムを用いる患者自己管理鎮痛法 | |
| Andolfatto et al. | A Prospective Case Series of Single‐syringe Ketamine–Propofol (Ketofol) for Emergency Department Procedural Sedation and Analgesia in Adults | |
| US10874358B2 (en) | Method and device for automatic identification of an opioid overdose and injection of an opioid receptor antagonist | |
| US12377215B1 (en) | Intelligent pharmaceutical delivery system with automatic shutoff and method of using | |
| JP2013526982A5 (cg-RX-API-DMAC7.html) | ||
| US6728574B2 (en) | System and method for patient-controlled relief of pain associated with electrical therapies | |
| AU2015343123B2 (en) | Respiratory parameter guided automated IV administration and IV tube clamp activation | |
| US20130172759A1 (en) | Systems And Methods For Using Photoplethysmography In The Administration Of Narcotic Reversal Agents | |
| US20130197430A1 (en) | Monitoring and delivery system for supplying patient with controlled dosage of substance reversal agent | |
| CN102316800A (zh) | 用于预防呼吸暂停的方法和装置 | |
| US20230078892A1 (en) | System and method for detecting ventilatory depression and for prompting a patient to breathe | |
| Kluger et al. | Patient-controlled analgesia: can it be made safer? | |
| WO2013138592A1 (en) | Monitoring and delivery system for supplying patient with controlled dosage of substance reversal agent | |
| US20070024439A1 (en) | Monitoring system for a residence | |
| US20200147307A1 (en) | Systems and method for detection and treatment of opioid overdose | |
| Cortes et al. | Improving the safety of patient-controlled analgesia infusions with safety interlocks and closed-loop control | |
| KR20130089913A (ko) | 집중 관리 모니터링 시스템 및 이를 이용한 모니터링 방법 | |
| Elliott | 6 Patient-controlled of acute pain analgesia in the management | |
| Sherman et al. | Patient-controlled analgesia devices and analgesic infusion pumps | |
| Williams | Saving lives, saving families: continuous monitoring for patients on opioids | |
| Jungquist | SAFE AND EFFECTIVE PAIN MANAGEMENT FOR THE HOSPITALIZED PATIENT | |
| McMullen et al. | Opiate overdose | |
| Fields et al. | Continuous Respiratory Monitoring and a “Smart” Infusion System Improve Safety of Patient-Controlled Analgesia in the Postoperative Period |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |